Correction: COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.
Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Departments of Internal Medicine and Pediatrics and the Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, OH, USA.
Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. [email protected]
National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA. [email protected]
- Published Article
- Publication Date
Sep 30, 2020
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 10/06/2020 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/32999436